|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Citius Pharmaceuticals (NASDAQ: CTXR) through any online brokerage.
The latest price target for Citius Pharmaceuticals (NASDAQ: CTXR) was reported by Maxim Group on November 30, 2021. The analyst firm set a price target for 4.00 expecting CTXR to rise to within 12 months (a possible 164.90% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Citius Pharmaceuticals (NASDAQ: CTXR) is $1.51 last updated Fri Dec 03 2021 21:00:04 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Citius Pharmaceuticals.
Citius Pharmaceuticals’s $Q1 earnings are confirmed for after-market on February 10, 2022.
There is no upcoming split for Citius Pharmaceuticals.
Citius Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.